title: Non-medical prescription drug use (NMPDU) and poor quality of life in the Swedish general population.
abstract: OBJECTIVE
  Quality of life has become an increasingly important measurement in the substance use field. The main aim of the present study was to examine the relationships between non-medical use of prescription analgesics and sedatives and poor quality of life in the general population.
  
  
  METHODS
  Data were drawn from a Swedish national household survey conducted in 2008-2009. A stratified sample of 58,000 individuals aged 15-64 was randomly selected, with a response rate of 38.3% (n = 22,095). We examined the relationships between non-medical prescription drug use and quality of life in a logistic regression analysis, controlling for other substance use and sociodemographic variables.
  
  
  RESULTS
  In the final logistic regression model, both non-medical use of prescription analgesics and sedatives were independently associated with poor quality of life. Non-medical use of prescription sedatives was the strongest correlate of poor quality of life among the substance use variables.
  
  
  CONCLUSIONS
  The associations between non-medical prescription drug use and poor quality of life might imply a need to better identify and provide treatment for this group, especially individuals with non-medical prescription sedative use, which seems to be a particularly strong correlate of poor quality of life.
  
  
  CONCLUSIONS
  Using a large, general population sample, the present paper is one of few to examine the relationships between non-medical prescription drug use and quality of life.
authors: Department of Clinical Sciences Lund, Division of Psychiatry, Lund University, Sweden.
authors: Tove
authors: T
authors: Abrahamsson
authors: Department of Clinical Sciences Lund, Division of Psychiatry, Lund University, Sweden.
authors: Mats
authors: M
authors: Berglund
authors: Department of Clinical Sciences Lund, Division of Psychiatry, Lund University, Sweden.
authors: Anders
authors: A
authors: Håkansson
mesh_terms: D000293:Adolescent; D000328:Adult; D000700:Analgesics; D005260:Female; D006306:Health Surveys; D006801:Humans; D006993:Hypnotics and Sedatives; D008297:Male; D008875:Middle Aged; D008960:Models, Psychological; D063487:Prescription Drug Misuse / Q000523:psychology* / Q000706:statistics & numerical data*; D011788:Quality of Life / Q000523:psychology*; D013223:Statistics as Topic; D019966:Substance-Related Disorders / Q000453:epidemiology; D013548:Sweden; D055815:Young Adult
chemical_list: D000700:Analgesics; D006993:Hypnotics and Sedatives
references: The WHOQOL Group. The World Health Organization Quality of Life assessment (WHOQOL): Position paper from the World Health Organization. Soc Sci Med. 1995;41:1403-1409.
references: Laudet AB. The case for considering quality of life in addiction research and clinical practice. Addic Sci Clin Pract. 2011; 6:44-55.
references: Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30:473-483.
references: Priebe S, Huxley P, Knight S, et al. Application and results of the Manchester Short Assessment of Quality of Life (MANSA). The International journal of social. psychiatry. 1999; 45(1):7-12.
references: Foster JH, Peters TJ, Marshall EJ. Quality of life measures and outcome in alcohol-dependent men and women. Alcohol. 2000; 22(1):45-52.
references: Rudolf H, Priebe S. Subjective quality of life and depressive symptoms in women with alcoholism during detoxification treatment. Drug Alcohol Depend. 2002; 1:71-76.
references: Heikkinen H, Jallinoja P, Saarni SI, et al. The impact of smoking on health-related and overall quality of life: A general population survey in Finland. Nicotine Tob Res. 2008; 10:1199-1207.
references: Ventegodt S, Merrick J. Psychoactive drugs and quality of life. Sci World J. 2003; 18:694-706.
references: Morales-Manrique CC, Palepu A, Castellano-Gomez M, et al. Quality of life, needs and interest among cocaine users: Differences by cocaine use intensity and lifetime severity of addiction to cocaine. Subst Use Misuse 2011; 46:390-397.
references: Andrade LF, Alessi SM, Petry NM. The impact of contingency management on quality of life among cocaine abusers with and without alcohol dependence. Am J Addict. 2012; 21:47-54.
references: Chou YC, Shih SF, Tsai WD, et al. Improvement of quality of life in methadone treatment patients in northern Taiwan: A follow-up study. BMC Psychiatry. 2013; 13:190.
references: Dietze P, Stoove M, Miller P, et al. The self-reported personal wellbeing of a sample of Australian injecting drug users. Addiction 2010; 105:2141-2148.
references: Fischer JA, Conrad S, Clavarino AM, et al. Quality of life of people who inject drugs: characteristics and comparisons with other population samples. Qual Life Res. 2013; 22:2113-2121.
references: Hernandez SH, Nelson LS. Prescription drug abuse: Insight into the epidemic. Clin Pharmacol Ther. 2010; 88:307-317.
references: Benyamin R, Trescot AM, Datta S, et al. Opioid complications and side effects. Pain Physician. 2008; 11(Suppl. II):S105-S120.
references: Lader M. Benzodiazepines revisited-will we ever learn. Addiction. 2011; 106:2086-2109.
references: Casati A, Sedefov R, Pfeiffer-Gerschel T. Misuse of medicines in the European Union: A systematic review of the literature. Eur Addict Res. 2012; 18:228-245.
references: Abrahamsson T, Hakansson A. Correlates of ecstasy use in the Swedish general population. Subst Use Misuse. 2013; 48:353-357.
references: Berge J, Hakansson A, Berglund M. Alcohol and drug use in groups of cannabis users: Results from a survey on drug use in the Swedish general population. Am J Addict. 2014; 23:272-279.
references: Hakansson A, Mickelsson K, Wallin C, et al. Anabolic androgenic steroids in the general population: User characteristics and associations with substance use. Eur Addict Res. 2012; 18:83-90.
references: The Swedish National Institute of Public Health. Hälsa på lika villkor - Resultat från nationella folkhälsoenkäten 2007 [Health on equal terms-Results from the national public health survey 2007]. Stockholm: The Swedish National Institute of Public Health; 2008.
references: Bjorkman T, Svensson B. Quality of life in people with severe mental illness. Reliability and validity of the Manchester Short Assessment of Quality of Life (MANSA). Nord J Psychiatry. 2005; 59:302-306.
references: Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption-II. Addiction. 1993; 88:791-804.
references: Reinert DF, Allen JP. The alcohol use disorders identification test: an update of research findings. Alcohol, Clin Exp Res. 2007; 31:185-199.
references: Novak SP, Herman-Stahl M, Flannery B, et al. Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States. Drug and alcohol dependence. 2009; 1:63-70.
references: Becker WC, Fiellin DA, Desai RA. Non-medical use, abuse and dependence on sedatives and tranquilizers among U.S. adults: Psychiatric and socio-demographic correlates. Drug Alcohol Depend. 2007; 8:280-287.
references: Becker WC, Sullivan LE, Tetrault JM, et al. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: Psychiatric, medical and substance use correlates. Drug Alcohol Depend. 2008; 1:38-47.
references: Hays RD, Wells KB, Sherbourne CD, et al. Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses. Arc Gen Psychiatry. 1995; 52:11-19.
references: Spitzer RL, Kroenke K, Linzer M, et al. Health-related quality of life in primary care patients with mental disorders. Results from the PRIME-MD 1000 Study. JAMA. 1995; 15:1511-1517.
references: United States Department of H, Human Services. Substance A, Mental Health Services Administration. Office of Applied S. National Survey on Drug Use and Health 2009; Inter-university Consortium for Political and Social Research (ICPSR) [distributor].
references: Janols LO, Liliemark J, Klintberg K, et al. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007. Nord J Psychiatry. 2009; 63:1977-2007.